Class IA antiarrhythmics affect risk of torsades de pointes how?

Prepare for the Mehlman Cardiology Exam. Engage with interactive quizzes, flashcards, and detailed explanations for each cardiology topic. Ace your exam with our comprehensive study tools!

Multiple Choice

Class IA antiarrhythmics affect risk of torsades de pointes how?

Explanation:
Class IA antiarrhythmics prolong repolarization by blocking potassium channels in addition to their sodium channel effects. This lengthens the action potential duration and the QT interval. Prolonged QT provides a substrate for early afterdepolarizations, which can trigger torsades de pointes, so these drugs increase the risk of TdP. It’s not correct to say they decrease risk or have no effect, and it’s not true that only class III prolongs the AP duration—class IA do as well, though through a different mechanism.

Class IA antiarrhythmics prolong repolarization by blocking potassium channels in addition to their sodium channel effects. This lengthens the action potential duration and the QT interval. Prolonged QT provides a substrate for early afterdepolarizations, which can trigger torsades de pointes, so these drugs increase the risk of TdP. It’s not correct to say they decrease risk or have no effect, and it’s not true that only class III prolongs the AP duration—class IA do as well, though through a different mechanism.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy